- Home
- INDP vs BREA Comparison
INDP vs BREA Comparison
Compare INDP & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- BREA
- Stock Information
- Founded
- INDP 2000
- BREA 2022
- Country
- INDP United States
- BREA Ireland
- Employees
- INDP N/A
- BREA N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- INDP Health Care
- BREA Consumer Discretionary
- Exchange
- INDP Nasdaq
- BREA Nasdaq
- Market Cap
- INDP 10.2M
- BREA 9.1M
- IPO Year
- INDP N/A
- BREA 2023
- Fundamental
- Price
- INDP $0.94
- BREA $0.64
- Analyst Decision
- INDP Strong Buy
- BREA
- Analyst Count
- INDP 2
- BREA 0
- Target Price
- INDP $8.50
- BREA N/A
- AVG Volume (30 Days)
- INDP 24.7K
- BREA 497.9K
- Earning Date
- INDP 11-12-2024
- BREA 12-27-2024
- Dividend Yield
- INDP N/A
- BREA N/A
- EPS Growth
- INDP N/A
- BREA N/A
- EPS
- INDP N/A
- BREA N/A
- Revenue
- INDP N/A
- BREA $1,268,367.00
- Revenue This Year
- INDP N/A
- BREA N/A
- Revenue Next Year
- INDP N/A
- BREA N/A
- P/E Ratio
- INDP N/A
- BREA N/A
- Revenue Growth
- INDP N/A
- BREA 606.55
- 52 Week Low
- INDP $0.84
- BREA $0.50
- 52 Week High
- INDP $3.10
- BREA $3.00
- Technical
- Relative Strength Index (RSI)
- INDP 34.68
- BREA 43.47
- Support Level
- INDP $0.94
- BREA $0.65
- Resistance Level
- INDP $1.06
- BREA $0.73
- Average True Range (ATR)
- INDP 0.05
- BREA 0.10
- MACD
- INDP 0.00
- BREA 0.00
- Stochastic Oscillator
- INDP 0.00
- BREA 13.85
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.